- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07943169
Wear, Clinical Performance and Computerized Occlusal Evaluation of Hybrid Versus Lithium Disilicates Ceramic CAD/CAM Overlays in Endodontically Treated Molars: A 24-Month Comparative Randomized Clinical Trial
This randomized clinical trial aims to compare the clinical performance, wear behavior and relative occlusal force distribution of hybrid ceramic and lithium disilicate CAD/CAM overlays in endodontically treated molars over a 24-month follow up period using Modified USPHS criteria, Geomagic control software and digital occlusal analyzer respectively
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Farah Khaled El Hindawy, PhD candidate
- Phone Number: +201008771378
- Email: farah-khaled@dentistry.cu.edu.eg
Study Contact Backup
- Name: Aya Mohamed Adly, Lecturer
- Phone Number: +201221528843
- Email: Aya.Mohamed@dentistry.cu.edu.eg
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Inclusion criteria of patients: Healthy patients, compliant, having good oral hygiene, willing to commit to the follow up periods, patients without parafunctional habits
- Inclusion criteria of teeth included: endodontically treated first or second molars, opposing teeth present, consistent root canal fillings, no apical lesion or mobility present, large access cavities with at least one missing wall
Exclusion Criteria:
- Exclusion criteria of patients: patients having systemic diseases, pregnant females, not willing to commit to the follow up periods, patients with poor oral hygiene, patients having parafunctional habits
- Exclusion criteria of teeth: endodontically treated anterior or premolar teeth, endodontically treated third molars ,inconsistent root canal filling, presence of periapical lesion or mobility, lack of opposing teeth, conservative access cavities
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Endodontically treated molars will be restored using lithium disilicate CAD/CAM overlays
Endodontically treated molars will receive lithium disilicate CAD/CAM overlays. Proper cavity preparation will be done based on the concepts of morphology driven preparation, followed by immediate dentin sealing, cavity optimization, scanning, milling and finally cementation of lithium disilicate overlay. |
Endodontically treated molars will be prepared to receive lithium disilicate CAD/CAM overlays. Preparation includes cuspal reduction of the buccal and lingual walls 1.5 to 2 mm, removal of all undermined enamel and slight flaring of the cavity walls to 6-10-degree divergence. Following cavity preparation, immediate dentin sealing and cavity optimization followed by scanning and milling of the restoration. Cementation will then follow based on manufacturer instructions using resin cement. Surface treatment including etching of the fitting surface using 9.5% hydrofluoric acid for 20 seconds followed by cleaning for 60 seconds using 37% phosphoric acid gel followed by silane application. |
|
Experimental: Experimental: Endodontically treated molars will be restored using Hybrid Ceramics CAD/CAM overlays
Endodontically treated molars will receive Hybrid ceramics CAD/CAM overlays. Proper cavity preparation will be done based on the concepts of morphology driven preparation, followed by immediate dentin sealing, cavity optimization, scanning, milling and finally cementation of lithium disilicate overlay. |
Endodontically treated molars will be prepared to receive hybrid ceramics overlays following the concept of morphology driven preparation. This includes cuspal reduction for the buccal and lingual walls, removal of all undermined enamel, slight flaring of the cavity walls to 6-10-degree divergence. After proper cavity preparation, immediate dentin sealing and cavity optimization will be done followed by scanning, milling and finally cementation of the overlay restoration. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wear Assessment
Time Frame: baseline, 12 and 24 months
|
The volumetric loss of the overlays will be measured by the software Geomagic Control Software |
baseline, 12 and 24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical performance (Marginal Adaptation)
Time Frame: baseline, 6, 12, 18 and 24 months
|
Marginal adaptation will be measured by two assessors following Modified USPHS criteria |
baseline, 6, 12, 18 and 24 months
|
|
Relative Occlusal load distribution
Time Frame: Immediately, 6 and 12 months
|
relative occlusal load distribution will be measured by digital occlusal analysis system OccluSense |
Immediately, 6 and 12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Cairo CONS 3-7-5
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
The dataset contains coded but potentially re-identifiable clinical and patient information. Per the study confidentiality plan, data access is restricted to the principal investigator and study supervisors only with records stored securely under password-protected, limited access systems. No plan for sharing individual participant data with external researchers is currently in place.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.